Cytological findings in blood, blood-forming organs, or the immune system

Exclusions from above levels

Show allHide

http://id.who.int/icd/entity/1800910986 – Haemorrhagic or haematological disorders of fetus or newborn
JA66.0 – Abnormal haematological finding on antenatal screening of mother
19 – Certain conditions originating in the perinatal period
JA66 – Clinical findings on antenatal screening of mother

MA16.0 – Abnormality of red blood cells
MA16.1 – Abnormality of white blood cells
MA16.Y – Other specified cytological findings in blood, blood-forming organs, or the immune system
MA16.Z – Cytological findings in blood, blood-forming organs, or the immune system, unspecified

MA10 – Abnormal serum enzyme levels
MA11 – Clinical findings of hormones in blood, blood-forming organs, or the immune system
MA12 – Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system
MA13 – Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system
MA14 – Immunological findings in blood, blood-forming organs, or the immune system
MA15 – Microbiological findings in blood, blood-forming organs, or the immune system
MA17 – Histological findings in blood, blood-forming organs, or the immune system
MA18 – Certain clinical findings of blood chemistry
MA19 – Certain abnormalities of plasma proteins
MA1A – Elevated erythrocyte sedimentation rate or abnormality of plasma viscosity
MA1Y – Other specified clinical findings in blood, blood-forming organs, or the immune system

Part of: 21: Symptoms, signs or clinical findings, not elsewhere classified